Abstract
Inflammatory bowel disease (IBD) is a multi-factorial, chronic inflammation of the gastrointestinal tract, containing ulcerative colitis (UC) and Crohn's disease (CD). In UC, inflammation and sores are confined morphologically and microscopically to the mucosa, the innermost surface of the colon and the rectum. Although, in CD, the infection is granulomatous and transmural, affecting the entire gastrointestinal tract from the mouth to the anus, with the skip area in-between. A Neuropeptide, substance P (SP), which acts as a neurotransmitter and as a neuromodulator, plays a vital role in the brain-gut axis under stress. Owing to the pro-inflammatory effects of SP, neuropeptide dysregulation induces inflammation in the intestine. There are variations in the distribution of substance P immunoreactive fibres in the various intestinal layers. The highest concentration of SP is in the mucosa and the lowest concentration in the lamina propria of the intestinal muscular membrane. Reduced vasoactive intestinal peptide (VIP) levels and elevated SP levels observed in the colonic mucosa of IBD by using immunohistochemistry and immunoassay. This literature review aims to find out the correlations between the level of substance P (SP) and disease activity. We conducted a literature review on IBD, SP, and we searched PubMed and Google Scholar for relevant articles in English. The result of the study supports a positive relationship between the level of substance P (SP) and disease activity, with increased concentration of substance p in the colon and rectum of CD and UC patients. It is concluded that patients with active CD, along with inflammatory changes, had elevated plasma SP levels and immunoreactivity of SP in the colon than those seen in control and inactive cases. These alterations are more prevalent in ulcerative colitis than Crohn's disease and are more prevalent in the moderately infected area than the least affected area of the intestine.
Highlights
BackgroundInflammatory bowel disease (IBD) is a chronic gastrointestinal tract inflammation with the relapsing and remitting course
In this traditional review article, our main focus was to examine the role of the neuropeptide substance P (SP) in the pathogenesis of inflammatory bowel disease (IBD) and to analyze whether or not there are a correlation and causation between the level of the substance P (SP) and the degree of inflammation in IBD
We find that dysregulation and imbalance of neuropeptides, primarily substance P, is responsible for inflammatory changes in IBD
Summary
Inflammatory bowel disease (IBD) is a chronic gastrointestinal tract inflammation with the relapsing and remitting course. Samples from the moderately affected UC colon, indicating an increase in the intensity and density of the immunoreactive nerve fibres of substance P in lamina propria. Correlation between the level of substance P and degree of inflammation in IBD patients This study indicates that the degree of inflammation is proportional to the change in SP immunoreactivity when the control specimens and the least to moderately affected UC specimens are related. It proposed that the effect of UC on the substance P immunoreactivity could be much greater than that demonstrated by the present information due to the absence of anti-inflammatory drugs in the control system. SP- Substance P, UC- Ulcerative Colitis, IBD- Inflammatory Bowel Disease, VIP -Vasoactive Intestinal Peptide, RIA-Radioimmunoassay
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
